Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-16-065340
Filing Date
2016-10-27
Accepted
2016-10-27 13:49:28
Documents
1
Period of Report
2016-10-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1441
  Complete submission text file 0001127602-16-065340.txt   2858
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Issuer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INSYS THERAPEUTICS, INC 1333 SOUTH SPECTRUM BLVD, SUITE 100 CHANDLER AZ 85286
Business Address
BRENNAN DANIEL (Reporting) CIK: 0001657999 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37568 | Film No.: 161954994